Dr. Twelves Describes Iniparib Clinical Trials

Christopher Twelves, MD

Published Online: Friday, April 1, 2011

Print

Email

Christopher Twelves, MD, Professor of Clinical Cancer Pharmacology and Oncology and Head of the Clinical Cancer Research Group at the University of Leeds in the United Kingdom Describes Iniparib Clinical Trials

View more videos of Christopher Twelves, MD.

Comment(s)

Your comments are valuable to us. Thank you.

Sorry, you must be logged in and registered to post a comment.

Related Articles

Cancer Screening: Are You Recommending the Right Intervals?

Now more than ever, oncology nurses need to be able to fill the knowledge gap and accurately educate their patients and the public about cancer screening tests and their frequency.

Chemotherapy Improves Survival in Older Women With Advanced ER-Negative Breast Cancer

Older women with estrogen receptor (ER)-negative metastatic breast cancer have a 39% lower risk of all-cause mortality if they receive chemotherapy within 6 months of their diagnosis.

Sentinel Lymph Node Test Has No Effect on Overall Survival in Women With Early-Stage Breast Cancer

It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.

Bringing the Oncology Community Together

Dr. Twelves Describes Iniparib Clinical Trials